China has stepped into an aging society. The social service development statistical bulletin 2015 published in July 2016 by Ministry of Civil Affairs showed that till the end of 2015, the amount of people ≥60 years of age had already approached to 222 million, which comprised 16.1% of the Chinese population, while the amount of people ≥65 years of age comprised 10.5% of the Chinese population was 143 million. 1 Hypertension is an independent risk factor for cardio-cerebral-vascular diseases and is a primary and contributory cause for death and disability in the elderly.
events and all-cause mortality. 2 Compared to younger patients with similar blood pressure elevation, the risks of cardiovascular and cerebrovascular events significantly increase in the elderly. Because of specialties in the pathogenesis and clinical manifestation in older patients with hypertension, physicians should pay more attention to the population characteristics and individual treatments.
Since the publication of guideline for hypertension prevention and management in China (2010) 3 for the management of hypertension, 9 and Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. 10 These updated guidelines further improved the prevention and control strategy of hypertension.
Recently, the American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) have published their joint guidelines for management and target of blood pressure control in patients ≥60 years of age. 11 Based on this, Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2011) is updated as to facilitate the prevention and management of hypertension in Chinese elderly.
| DEFIN ITION AND ME ASUREMENT OF HYPERTENSION IN THE ELDERLY

| Definition of hypertension in the elderly
A clinical diagnosis of hypertension in the elderly is established by demonstrating apersistent or at least 3 times in different days systolic blood pressure (SBP) ≥ 140 mm Hg (1 mm Hg = 0.133 kpa) and/or a diastolic blood pressure (DBP) ≥ 90 mm Hg in sitting position in patients ≥ 60 years of age. In addition, isolated systolic hypertension is defined as SBP ≥ 140 mm Hg and DBP < 90 mm Hg.
| Blood pressure measurement in the elderly
It is very important to measure BP accurately in the diagnosis and management of hypertension in the elderly, and the followings should be attentioned: (i) Patients should sit calmly for 5 minutes before BP measurement, usually in sitting position, with cuff at heart level; (ii) compared with office BP measurement, out-of-office BP monitoring (especially home blood pressure monitoring, HBPM) represents a more reliable assessment of actual BP; (iii) patient BP should be measured in both arms during the initial visit;(iv) BP should be measured at 1-minute and 3-minute intervals after assumption of standing position to make sure if there is orthostatic hypotension during the initial visit or after management adjustment;
(v) HBPM could be measured 2-3 times and then averaged; and (vi) pulse rate should be measured while BP measurement. Cutoff values of BP by different measuring methods: Office BP < 140/90 mm Hg, HBPM < 135/85 mm Hg, ABPM < 130/ 80 mm Hg, and daytime ABPM < 135/85 mm Hg.
In recent years, automated office blood pressure using oscillometric devices is recommended, and hypertension is defined as values ≥ 135 mm Hg in SBP or ≥85 mm Hg in DBP. A study in Canada showed that in community-dwelling residents aged ≥ 65 years untreated for hypertension, relative to the reference BP categories of 110-119 mm Hg SBP and 60-69 mm Hg DBP, cardiovascular risk was significant elevated at a SBP of 135-144 mm Hg (HR 1.66, 95% CI 1.09, 2.54; P = .02), at a DBP of 80-89 mm Hg (HR 1.72, 95% CI 1.21, 2.45; P = .003) 12 HBPM is very important in BP monitoring and treatment evaluation for elderly patients with hypertension, so they should be encouraged to master the basic measuring method of cuff-electronic sphygmomanometer and to enhance self-management of BP. However, HBPM is not recommended in elderly patients with mental stress or anxiety. ABPM could be used in patients with a large blood pressure variability or with poor controlled BP, and it could be used as a routine examine tool in the diagnosis and efficacy monitoring in elderly hypertensive patients if possible. However, more large-scale clinical trials are needed to establish the normal range of ambulatory blood pressure in the elderly.
| EPIDEMIOLOGY AND STATUS OF
PREVENTION AND TREATME NT IN HYPERTEN SIVE ELDERLY
Comprehensive report on national nutrition and health status survey 2002 showed that the prevalence of hypertension in Chinese population older than 60 is around 49.1% in 2002, 13 but the prevalence moved up to 58.9% in 2012 according to Report on nutrition and chronic diseases in China 2015, 14 and the rising range is approximately 20%. The prevalence of hypertension progressively increases with age, and approximately 3 in 5 elderly people suffer from hypertension in China. American data in 2011-2014 demonstrated that in 65-to 74-year-old people, hypertension prevalence was 63.4% in men and 64.3% in women, and in people ≥75 years of age, the prevalence was 72.3% in men and 79.9% in women. 15 the global burden of disease study on global, regional, and national comparative risk assessment of behavioral, environmental, and occupational, and metabolic risks demonstrated that hypertension was at top of the list. 17 In addition, hypertension is the most important risk factor for stroke. 18 In recent years, the rate of awareness, treatment, and control for hypertension in China has been improved, which was 53.7%, 48.8%, and 16.1%, respectively, in ≥60 years hypertensive patients in 2012, 14 but there still remains a wide range with western developed countries. The rate of awareness, treatment, and control of hypertension was 86.1%, 82.2%, and 50.5%, respectively, in the USA 2011-2012. 19 
| CHARACTERISTICS OF HYPERTENSION
IN THE ELD ERLY
| Pathophysiological characteristics 20
Age-associated fatigue fracture of elastin and collagen deposition increase atherosclerotic arterial diseases, hypertrophy, and sclerosis of muscular arteries and arterioles, and these vascular changes lead to the following: (i) Large vessels become less distensible, resulting in increasing in the left ventricular ejection resistance and late systolic blood pressure (SBP) augmentation; (ii) the decreased arterial compliance and the ability to buffer the blood pressure, which promotes the early return of the reflected waves from the diastole to the systolic period, cause an increase in systolic pressure and pulse pressure but a fall in diastolic pressure; (iii) reduction in the elasticity of the aorta, vascular elasticity, and reserve capacity, which results in the increase in systolic blood flow from ventricle to peripheral artery and the decrease in blood volume in elastic reserve vessels at early diastolic period, causes decrease in diastolic blood pressure (DBP); and (iv) the lumen of arterioles is narrowed or even closed because of the age-related small arteries arteriosclerosis, which causes a significantly increase in total peripheral resistances. 21 1. Isolated systolic hypertension: The systolic hypertension in the elderly increases with age, while DBP declines slightly after 60 years old. Compared with DBP, SBP is more closely related to the target organ damage, and it is a stronger independent risk factor for incident cardiovascular events.
| Clinical characteristics of hypertension in the elderly
2.
Increased pulse pressure: Pulse pressure is a measure of vascular stiffness, which is associated with physiological aging and various diseases that lead to vascular aging. Pulse pressure augmentation is a characteristic in the elderly hypertension, which is defined as pulse pressure >40 mm Hg. For the elderly, the pulse pressure can be as high as 50-100 mm Hg. Multiple studies demonstrated that pulse pressure in the elderly is positively correlated with all-cause death, cardiovascular death, stroke, and coronary heart disease. [22] [23] [24] [25] However, another research showed that, for predicting cardiovascular events in elderly patients, pulse pressure is no better than SBP. 26 3. Blood pressure fluctuation: With the increase in age, blood pressure in elderly patients with hypertension tends to fluctuate significantly with mood, season, and body position. The early morning hypertension surge tends to occur most frequently in the elderly. Blood pressure fluctuation in the elderly increases the difficulty of blood pressure treatment. In addition, elderly hypertensive patients are often coexisted with coronary artery, renal artery, carotid artery, and intracranial arterial disease, when blood pressure fluctuates sharply, cardiovascular events and target organ damage can be significantly increased.
Orthostatic hypotension:
Orthostatic hypotension is defined as a reduction of ≥20 mm Hg in SBP or ≥10 mm Hg in DBP from lying to standing position within 3 minutes, with insufficient perfusion symptoms, such as dizziness or syncope. 3 Orthostatic hypotension is common in the elderly because of age-related blood vessel stiffness and autonomic neuropathy, especially when accompanied with diabetes mellitus, hypovolemia, use of diuretic, vasodilator, and psychotropic medicine. Therefore, lying and standing blood pressure should be measured during the diagnosis and treatment of hypertension in the elderly.
Postprandial hypotension (PPH): It is defined as systolic blood
pressure dropped ≥ 20 mm Hg within 2 hours after meal, or preprandial SBP ≥ 100 mm Hg, and postprandial SBP < 90 mm Hg with symptoms of dizziness, fainting, angina pectoris, and other hypotensive symptoms after eating. 27 6. Abnormal blood pressure circadian rhythm: An adult's BP normally decreases during the night, and a nighttime BP fall of 10%-20% of daytime values is defined as dipper type blood pressure rhythm. Elderly patients often have abnormal circadian rhythm of blood pressure, such as a nighttime BP fall < 10% (nondipping pattern) or >20% (extreme-dipping pattern), and even a reversedipping pattern which nighttime BP reversely increases. In patients with abnormal blood pressure circadian rhythm, it is more likely to develop heart, brain, or kidney damage. 28 The incidence of nondipping pattern blood pressure in elderly patients can reach to 60% or more. Compared to younger patients, the circadian abnormality of blood pressure is more closely related to the damage of target organs in the elderly.
7.
Office hypertension: White-coat hypertension is defined as SBP greater than 140 mm Hg or DBP greater than 90 mm Hg measured by a doctor or nurse in the clinic together with a normal daytime by ambulatory BP monitoring or home blood pressure measurements. White-coat hypertension is common in the elderly and may lead to overtreatment. For patients with office hypertension, it is encouraged to strengthen the blood pressure monitoring and family self-test. When necessary, ABPM is used to assess the presence of office hypertension. It is recommended to check the blood pressure gauge if necessary to avoid measurement errors. Besides that, patients with office hypertensive are often associated with metabolic abnormalities, which increases the cardio-cerebral-vascular risks.
Multiple diseases coexistence and many complications: Elderly
hypertension is often associated with ASCVD and other risk factors for cardiovascular and cerebrovascular diseases, and some patients suffer from multiple diseases meanwhile. If BP cannot be well controlled long term, it is more likely to cause or aggravate target organ damage and increase the mortality of cardio-cerebral-vascular diseases and total mortality significantly. However, symptoms of hypertension or accompanying diseases in some elderly patients are not typical, which can easily lead to missed diagnosis, so comprehensive evaluation should be carried out to establish reasonable treatment measures. Cerebrovascular disease is common in elderly patients, which needs more attention to screening and evaluation. If the patient has bilateral carotid stenosis (≥70%) or severe intracranial arterial stenosis, excessive reduction or fluctuation of blood pressure may increase the risk of ischemic stroke. 
| TH E MAIN CLINICAL EVIDENCE FOR THE TREATMENT OF HYPERTENSION IN ELDERLY PATIEN TS
Researches including systolic hypertension in the elderly program (SHEP), 29 Swedish trail in old patients with hypertension (STOP-H), 30 systolic hypertension in Europe (Syst-Eur), 24 and the study on cognition and prognosis in the elderly (SCOPE) 31 had confirmed that LIU ET AL.
| 109 antihypertensive treatment of elderly hypertension reduces the incidence and mortality of cardio-cerebral-vascular disease, as well as the risk of cognitive decline and cardiovascular events. Elderly men over the age of 70 with high pulse pressure and cardiovascular complications have more benefit. Systolic hypertension in China (Syst-China) 23 demonstrated that antihypertensive therapy reduces mortality by 55% in elderly hypertensive patients. Subgroup analysis in HOT-CHINA 32 showed that antihypertensive therapy for 3050 very elderly patients (aged between 80 and 90 (82.6 AE 2.5)) has high control rate, low incidence of adverse events accompany with good efficacy, safety, and compliance. Hypertension in the very elderly trial (HYVET) 33 was a large-scale, randomized, double-blind, placebo-controlled study of hypertension patients over 80 years old, and a total of 3845 very elderly patients (age between 80 and 105, mean age 83.6 years) were enrolled, including 1526 Chinese patients, and median follow-up was 1.8 years (1-5 years). In the active-treatment group, the average blood pressure was 144/78 mm Hg compared with 161/84 mm Hg of placebo group. In an intention-to-treat analysis, active treatment was associated with a 21% reduction in the rate of death from any cause (P = .019), a 30% reduction in the rate of stroke (P = .06), a 39% reduction in the rate of death from stroke (P = .05), a 64% reduction in the rate of heart failure (P < .001), and a 34% reduction in the rate of severe cardiovascular events (P < .001). The Felodipine Event Reduction (FEVER) trial 34 was a prospective, multicenter, randomized, doubleblind controlled trial. A total of 9711 randomly assigned Chinese patients aged 50-79 years were included in the intention-to-treat analysis. The subgroup analysis of elderly 35 included 3179 patients showed that in hypertensive patients aged >65 years, significant reductions in stroke were found in elderly hypertensive patients (À44%, P < .001) when their SBP was lowered to a mean just <140 mm Hg (rather than 145 mm Hg), significant reductions (À47%, À51%, À36%, and À49%, P =< .001, 0.002, 0.013, and 0.004) were also found in cardiovascular events, cardiac events, all deaths, and cardiovascular death. However, the results in Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) 36 assigned 9361 persons more than 50 years old with a systolic blood pressure of 130 mm Hg or higher and an increased cardiovascular risk, excluding diabetes mellitus, stroke, acute renal insufficiency (eGFR < 20 mL/min/1.73 m 2 ), recent acute coronary syndrome, hospitalization for heart failure, and patients whose SBP were lower than 110 mm Hg in 1 minute when changed to standing position. Patients used automatic sphygmomanometer to test blood pressure by themselves, throughout the 3.26 years of follow-up; the mean systolic blood pressure was 121.5 mm Hg in the intensive-treatment group and 134.6 mm Hg in the standard-treatment group, and the result showed that enhanced antihypertensive therapy can reduce the major cardiovascular events and all-cause death further. 39 The elderly patients (≥75 years old) benefit from the enhanced antihypertensive treatment with no significant increase in severe adverse effects. 40 Heart outcomes prevention evaluation-3 trial (HOPE-3) 41 It is suggested to adopt individualized and graded treatment strategies for elderly patients with high blood pressure combined with target organ damages including heart, brain, and kidney: to lower BP of <150/90 mm Hg at first, and then to <140/90 mm Hg for the well-tolerated people. For those patients whose age Hg. The range of blood pressure reduction should be associated with baseline of BP, the higher the baseline blood pressure, the greater the depressurizing range is. Antihypertensive drugs lower the systolic blood pressure more efficiently than diastolic blood pressure. It is emphasized to ensure SBP to reach the target and to decrease BP gradually if tolerated for elderly patients rather than too fast and excessively.
Elderly hypertensive patients are often combined with multiple diseases and many ASCVD risk factors and/or target organ damages, and most of them need two or more antihypertensive drugs for combination therapy to achieve the target. The 
a. Salt restriction
It is very important to limit salt intake; salt-sensitive hypertension is common in the elderly. Daily salt intake less than 6 g is recommended 43 However, too aggressive salt restriction may cause hyponatremia.
b. Balanced diet
Elderly patients should be encouraged to eat all kinds of fresh vegetables, fruits, fish, beans and bean products, whole grains, skimmed milk, and other foods rich in potassium, calcium, dietary fiber, and polyunsaturated fatty acids.
c. Quit smoking and avoid secondhand smoke
Smoking causes an increase in the incidence and mortality of cardiovascular events, so it is suggested to quit smoking or avoid exposure to secondhand smoke.
d. Alcohol limitation
Elderly people are not encouraged to drink. It is generally agreed that alcohol intake should be limited to <25 g/d in men and <15 g/d in women. Besides that, it should be noticed that alcohol intake may affect the drug efficacy. 
Key point 2. Treatment strategies of hypertension in the elderly
| Antihypertensive therapy for very elderly and frail senile patients with hypertension
Very elderly patients are defined as patients more than 80 years old.
It is recommended to control BP < 150/90 mm Hg for very elderly patients whom in good health condition, and BP can be reduced to <140/90 mm Hg if tolerant. 45 The 
| EPILOGUE
Antihypertensive therapy of elderly hypertensive patients reduces the risk of target organ damage, cardiovascular events, and death. At present, the treatment, control, and target rate of elderly hypertensive patients in China are generally low. We hope that more elderly hypertensive patients could benefit from the antihypertensive treatment through the spread of the Chinese expert consensus on the diagnosis and treatment of hypertension, to improve the prevention and control strategy of cardiovascular and cerebrovascular diseases.
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T A B L E 1 The BP target and drug selection in elderly patients
Concomitant diseases Antihypertensive target and drug recommendation
Stroke BP-lowering therapy for patients with acute ischemic stroke should be carefully performed in the first week, and it is suggested to deal with anxiety, pain, nausea, vomiting, and higher cranial pressure first. If BP constantly increases to ≥200/110 mm Hg, antihypertensive drug should be used to reduce BP gradually (the reduction <15% over the first 24 h), and BP changes should be closely observed
For patients with ischemic stroke eligible for thrombolytic therapy, BP should be controlled within 180/100 mm Hg
The patient with acute ischemic stroke can restore the antihypertensive drugs which used before the onset of stroke or initiate antihypertensive therapy several days after the onset of the disease when in stable condition and BP consistently >140/ 90 mm Hg
The long-term control target of BP for patients with ischemic stroke is <140/90 mm Hg. In patients with lacunar cerebral infarction recently, a lower level <130/80 mm Hg should be targeted if possible Early positive antihypertensive therapy in patients with acute intracerebral hemorrhage may improve the prognosis, and blood pressure can be reduced to 140/90 mm Hg if no contraindications present. Antihypertensive therapy should be initiated when blood pressure ≥180/100 mm Hg with intracranial pressure increased, and the target BP is 160/90 mm Hg
The target of BP in patients with intracerebral hemorrhage is <130/80 mm Hg
Coronary heart disease
The target of BP control should be <140/90 mm Hg in principle and even < 130/80 mm Hg if can be tolerant. There are greater benefits from beta-blockers and ACE inhibitors, and ARBs can be chosen when ACEI is intolerant. Calcium antagonists are to be preferred for patients with angina or uncontrolled hypertension. Physicians should be cautious when DBP < 60 mm Hg and closely monitor the BP to achieve the target
Chronic heart failure
The target of BP control is <130/80 mm Hg and <140/90 mm Hg for very elderly patients. Beta-blockers, ACE inhibitors, diuretics, and aldosterone antagonist are recommended as first choice if no contraindication. ARBs can be chosen when ACEI is intolerant
Renal insufficiency The target of BP control is <130/80 mm Hg and <140/90 mm Hg for very elderly patients. ACEI and ARBs are recommended as first choice if no contraindication. It is suggested to take drugs from small dosage and monitor the changes of kidney function and potassium. CCB, loop diuretics, and alpha-and beta-blockers can be used for patients with CKD Stage 4 (eGFR < 30 mL/min/1.73 m 2 ),ACEI and ARBs should be used with caution
Diabetes mellitus
The recommendation is to lower BP < 140/90 mm Hg and even <130/80 mm Hg if tolerant, and ACEI and ARBs are recommended as first choice
